EX-23.1
Published on February 27, 2023
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1.Registration Statement (Form S-8 No. 333-211209) pertaining to the 2016 Equity Incentive Plan of ÄÐÈ˹¬µî.,
2.Registration Statement (Form S-8 No. 333-144040) pertaining to the 2007 Equity Incentive Plan of ÄÐÈ˹¬µî.,
3.Registration Statement (Form S-8 No. 333-190899) pertaining to the 2005 Stock Incentive Plan and 2007 Equity Incentive Plan of PROLOR Biotech, Inc. (formerly Modigene Inc.),
4.Registration Statement (Form S-8 No. 333-190900) pertaining to the Amended and Restated 2007 Equity Incentive Plan of ÄÐÈ˹¬µî., and
5.Registration Statement (Form S-8 No. 333-206489) pertaining to the 2003 Employee Incentive Stock Option Plan of BioReference Laboratories, Inc.
of our reports dated February 27, 2023, with respect to the consolidated financial statements and schedule of ÄÐÈ˹¬µî. and subsidiaries and the effectiveness of internal control over financial reporting of ÄÐÈ˹¬µî. and subsidiaries included in this Annual Report (Form 10-K) of ÄÐÈ˹¬µî. and subsidiaries for the year ended December 31, 2022.
ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý/s/ Ernst & Young LLP
ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý
Miami, Florida
February 27, 2023